Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cronos Group Inc.

CRONNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.56
$0.06(2.61%)
U.S. Market is Open • 14:31

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap961.5M
P/E Ratio-102.17
EPS (TTM)$-0.02
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$2.27
3 Months$3.22
1 Year Target$3.04

CRON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cronos Group Inc. (CRON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -102.17 and a market capitalization of 961.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.40%
5-Day Change
-1.96%
1-Month Change
-3.85%
3-Month Change
-23.55%
6-Month Change
-1.19%
Year-to-Date (YTD) Change
-7.41%
1-Year Change
34.41%
3-Year Change
27.55%
5-Year Change
-76.57%
All-Time (Max) Change
1415.15%

Contact Information

14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

4,590 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions